Lista de obras - Kevin Petrie - Dominio Público Uruguay

A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy

artículo científico publicado en 2017

Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regu

artículo científico publicado en 2005

Clinical translation of epigenetics in cancer: eN-CORe--a report on the second workshop

scientific article published on 01 November 2005

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease

artículo científico publicado en 2015

Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma

artículo científico publicado en 2015

DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia

artículo científico publicado en 2007

Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice.

artículo científico publicado en 2016

Derepression in the desert: the third workshop on clinical translation of epigenetics in cancer therapeutics

artículo científico publicado en 2008

Differentiation therapy of acute myeloid leukemia: past, present and future

artículo científico publicado en 2009

Histone deacetylase inhibitors in APL and beyond.

artículo científico publicado en 2007

Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia

artículo científico publicado en 2012

Lineage restriction of the RARalpha gene expression in myeloid differentiation

artículo científico publicado en 2001

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

artículo científico publicado en 2005

Marked for death

scientific article published on 01 May 2008

Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastoma

artículo científico publicado en 2015

Molecular target-based treatment of human cancer: summary of the 10th international conference on differentiation therapy

artículo científico publicado en 2005

Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.

artículo científico publicado en 2015

New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK.

artículo científico publicado en 2013

Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein

artículo científico publicado en 2000

Retinoblastoma protein and the leukemia-associated PLZF transcription factor interact to repress target gene promoters

artículo científico publicado en 2008

Retinoic acid receptor γ is a therapeutically targetable driver of growth and survival in prostate cancer

artículo científico publicado en 2020

Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer

artículo científico publicado en 2015

Semi-Quantitative Mass Spectrometry in AML Cells Identifies New Non-Genomic Targets of the EZH2 Methyltransferase.

artículo científico publicado en 2017

Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein.

artículo científico publicado en 2012

Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer

artículo científico publicado en 2015

The Protozoan Inhibitor Atovaquone Affects Mitochondrial Respiration and Shows <i>In Vitro</i> Efficacy Against Glucocorticoid-Resistant Cells in Childhood B-Cell Acute Lymphoblastic Leukaemia

publication published on 15 March 2021

The histone deacetylase 9 gene encodes multiple protein isoforms

artículo científico publicado en 2003

p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance.

artículo científico publicado en 2016

Lista de obras de Kevin Petrie

A Case of AML Characterized by a Novel t(4;15)(q31;q22) Translocation That Confers a Growth-Stimulatory Response to Retinoid-Based Therapy

Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regu

Clinical translation of epigenetics in cancer: eN-CORe--a report on the second workshop

Combined MYC and P53 defects emerge at medulloblastoma relapse and define rapidly progressive, therapeutically targetable disease

Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma

DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia

Deregulated expression of HDAC9 in B cells promotes development of lymphoproliferative disease and lymphoma in mice.

Derepression in the desert: the third workshop on clinical translation of epigenetics in cancer therapeutics

Differentiation therapy of acute myeloid leukemia: past, present and future

Histone deacetylase inhibitors in APL and beyond.

Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia

Lineage restriction of the RARalpha gene expression in myeloid differentiation

Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

Marked for death

Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastoma

Molecular target-based treatment of human cancer: summary of the 10th international conference on differentiation therapy

Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity.

New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK.

Recruitment of the nuclear receptor corepressor N-CoR by the TEL moiety of the childhood leukemia-associated TEL-AML1 oncoprotein

Retinoblastoma protein and the leukemia-associated PLZF transcription factor interact to repress target gene promoters

Retinoic acid receptor γ is a therapeutically targetable driver of growth and survival in prostate cancer

Selective Inhibition of SIN3 Corepressor with Avermectins as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer

Semi-Quantitative Mass Spectrometry in AML Cells Identifies New Non-Genomic Targets of the EZH2 Methyltransferase.

Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein.

Targeting the SIN3A-PF1 interaction inhibits epithelial to mesenchymal transition and maintenance of a stem cell phenotype in triple negative breast cancer

The Protozoan Inhibitor Atovaquone Affects Mitochondrial Respiration and Shows <i>In Vitro</i> Efficacy Against Glucocorticoid-Resistant Cells in Childhood B-Cell Acute Lymphoblastic Leukaemia

The histone deacetylase 9 gene encodes multiple protein isoforms

p53 Loss in MYC-Driven Neuroblastoma Leads to Metabolic Adaptations Supporting Radioresistance.